145 related articles for article (PubMed ID: 14670593)
21. Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds.
Phillips T; Jenkinson L; McCrae C; Thong B; Unitt J
J Virol Methods; 2011 May; 173(2):182-8. PubMed ID: 21300110
[TBL] [Abstract][Full Text] [Related]
22. Sequence requirements for viral RNA replication and VPg uridylylation directed by the internal cis-acting replication element (cre) of human rhinovirus type 14.
Yang Y; Rijnbrand R; McKnight KL; Wimmer E; Paul A; Martin A; Lemon SM
J Virol; 2002 Aug; 76(15):7485-94. PubMed ID: 12097561
[TBL] [Abstract][Full Text] [Related]
23. Interactions of Rice tungro bacilliform pararetrovirus and its protein P4 with plant RNA-silencing machinery.
Rajeswaran R; Golyaev V; Seguin J; Zvereva AS; Farinelli L; Pooggin MM
Mol Plant Microbe Interact; 2014 Dec; 27(12):1370-8. PubMed ID: 25122481
[TBL] [Abstract][Full Text] [Related]
24. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
Dave RS; McGettigan JP; Qureshi T; Schnell MJ; Nunnari G; Pomerantz RJ
Virology; 2006 May; 348(2):489-97. PubMed ID: 16480752
[TBL] [Abstract][Full Text] [Related]
25. Medicine: silencing viruses with RNA.
Carmichael GG
Nature; 2002 Jul; 418(6896):379-80. PubMed ID: 12140542
[No Abstract] [Full Text] [Related]
26. Antiviral activity and possible mechanism of action of constituents identified in Paeonia lactiflora root toward human rhinoviruses.
Ngan LT; Jang MJ; Kwon MJ; Ahn YJ
PLoS One; 2015; 10(4):e0121629. PubMed ID: 25860871
[TBL] [Abstract][Full Text] [Related]
27. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins.
Boden D; Pusch O; Silbermann R; Lee F; Tucker L; Ramratnam B
Nucleic Acids Res; 2004; 32(3):1154-8. PubMed ID: 14966264
[TBL] [Abstract][Full Text] [Related]
28. Anti-rhinovirus-specific activity of the alpha-sympathomimetic oxymetazoline.
Koelsch S; Tschaikin M; Sacher F
Arzneimittelforschung; 2007; 57(7):475-82. PubMed ID: 17803062
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of rhinovirus replication in in organ culture by a potential antiviral drug.
DeLong DC; Reed SE
J Infect Dis; 1980 Jan; 141(1):87-91. PubMed ID: 6245149
[TBL] [Abstract][Full Text] [Related]
30. [The potential of synthetic small interfering RNA-based antiviral drugs for influenza treatment].
Pashkov EA; Faizuloev EB; Svitich OA; Sergeev OV; Zverev VV
Vopr Virusol; 2020 Sep; 65(4):182-190. PubMed ID: 33533221
[TBL] [Abstract][Full Text] [Related]
31. Modulation of HIV-1 replication by RNA interference.
Jacque JM; Triques K; Stevenson M
Nature; 2002 Jul; 418(6896):435-8. PubMed ID: 12087358
[TBL] [Abstract][Full Text] [Related]
32. Large-scale production of dsRNA and siRNA pools for RNA interference utilizing bacteriophage phi6 RNA-dependent RNA polymerase.
Aalto AP; Sarin LP; van Dijk AA; Saarma M; Poranen MM; Arumäe U; Bamford DH
RNA; 2007 Mar; 13(3):422-9. PubMed ID: 17237359
[TBL] [Abstract][Full Text] [Related]
33. Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication.
Yamamoto T; Omoto S; Mizuguchi M; Mizukami H; Okuyama H; Okada N; Saksena NK; Brisibe EA; Otake K; Fuji YR
Microbiol Immunol; 2002; 46(11):809-17. PubMed ID: 12516779
[TBL] [Abstract][Full Text] [Related]
34. Design and validation of small interfering RNA on respiratory syncytial virus M2-2 gene: A potential approach in RNA interference on viral replication.
Chin VK; Atika Aziz NA; Hudu SA; Harmal NS; Syahrilnizam A; Jalilian FA; Zamberi S
J Virol Methods; 2016 Oct; 236():117-125. PubMed ID: 27432115
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line.
Konishi M; Wu CH; Wu GY
Hepatology; 2003 Oct; 38(4):842-50. PubMed ID: 14512871
[TBL] [Abstract][Full Text] [Related]
36. A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.
Kim J; Jung YK; Kim C; Shin JS; Scheers E; Lee JY; Han SB; Lee CK; Neyts J; Ha JD; Jung YS
J Med Chem; 2017 Jul; 60(13):5472-5492. PubMed ID: 28581749
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.
Eckstein A; Grössl T; Geisler A; Wang X; Pinkert S; Pozzuto T; Schwer C; Kurreck J; Weger S; Vetter R; Poller W; Fechner H
Antiviral Res; 2010 Oct; 88(1):86-94. PubMed ID: 20708037
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action.
Chang J; Taylor JM
J Virol; 2003 Sep; 77(17):9728-31. PubMed ID: 12915586
[TBL] [Abstract][Full Text] [Related]
39. Endoribonuclease-prepared short interfering RNAs induce effective and specific inhibition of human immunodeficiency virus type 1 replication.
Gimenez-Barcons M; Clotet B; Martinez MA
J Virol; 2007 Oct; 81(19):10680-6. PubMed ID: 17652404
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic inhibition of yellow head virus multiplication in infected shrimps by YHV-protease dsRNA.
Tirasophon W; Yodmuang S; Chinnirunvong W; Plongthongkum N; Panyim S
Antiviral Res; 2007 May; 74(2):150-5. PubMed ID: 17166601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
